Related Experiment Video
Updated: Feb 16, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Extracorporeal membrane oxygenation in congenital heart disease
Kiona Y Allen1, Catherine K Allan2, Lillian Su3
1Department of Pediatrics, Northwestern University Feinberg School of Medicine, Ann & Robert H. Lurie Children's Hospital of Chicago, Box 21, 225 E Chicago Ave, Chicago, IL 60610.
Abstract:
This review article will discuss the indications for and outcomes of neonates with congenital heart disease who receive extracorporeal membrane oxygenation (ECMO) support. Most commonly, ECMO is used as a perioperative bridge to recovery or temporary support for those after cardiac arrest or near arrest in patients with congenital or acquired heart disease. What had historically been considered a contraindication to ECMO, is evolving and more of the sickest and most complicated babies are cared for on ECMO. Given that, it is imperative for aggressive survellience for long-term morbidity in survivors, particularly neurodevelopmental outcomes.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Rheumatic Heart Disease III: Medical Management
Rheumatic Heart Disease IV: Nursing Management
Anatomy of the Heart
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

